Published in Kidney Int on March 01, 2005
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney Int (2013) 1.60
Pathophysiology of acute kidney injury. Compr Physiol (2012) 1.56
Ischemia-reperfusion and immediate T cell responses. Cell Immunol (2007) 1.55
Human and murine obliterative bronchiolitis in transplant. Proc Am Thorac Soc (2007) 1.45
Outpatient nephrology referral rates after acute kidney injury. J Am Soc Nephrol (2011) 1.27
Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes. Kidney Int (2008) 1.17
Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol (2009) 1.11
Acute Kidney Injury Biomarkers - Needs, Present Status, and Future Promise. Nephrol Self Assess Program (2006) 1.11
Pivotal role of Toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflammasome complex in experimental tubule-interstitial nephritis. PLoS One (2011) 0.96
Distinct effects on long-term function of injured and contralateral kidneys following unilateral renal ischemia-reperfusion. Am J Physiol Renal Physiol (2011) 0.96
Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. Am J Physiol Renal Physiol (2012) 0.96
Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis. Mol Med (2008) 0.94
CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients. Am J Respir Crit Care Med (2008) 0.93
Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats. Am J Transplant (2013) 0.87
The loss of renal dendritic cells and activation of host adaptive immunity are long-term effects of ischemia/reperfusion injury following syngeneic kidney transplantation. Kidney Int (2012) 0.83
Long-term remote organ consequences following acute kidney injury. Crit Care (2015) 0.82
Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5. Am J Physiol Renal Physiol (2011) 0.82
Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury. Drug Discov Today Dis Mech (2007) 0.79
T lymphocytes and acute kidney injury: update. Nephron Clin Pract (2014) 0.78
Does Renal Repair Recapitulate Kidney Development? J Am Soc Nephrol (2016) 0.78
The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury. Cell Death Dis (2017) 0.75
High Risk of Herpes Zoster among Patients with Advance Acute Kidney Injury--A Population-Based Study. Sci Rep (2015) 0.75
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med (2004) 3.59
Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int (2009) 2.53
Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy. Am J Physiol Renal Physiol (2007) 2.46
Domino paired kidney donation: a strategy to make best use of live non-directed donation. Lancet (2006) 2.38
Inflammatory cells in ischemic acute renal failure. Kidney Int (2004) 2.20
Clinical results from transplanting incompatible live kidney donor/recipient pairs using kidney paired donation. JAMA (2005) 2.15
The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol (2008) 2.08
Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol (2008) 2.03
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
The innate immune response in ischemic acute kidney injury. Clin Immunol (2008) 1.98
A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol (2006) 1.77
B cell deficiency confers protection from renal ischemia reperfusion injury. J Immunol (2003) 1.73
Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int (2008) 1.67
Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J (2006) 1.61
Interactive effects of mechanical ventilation and kidney health on lung function in an in vivo mouse model. Am J Physiol Lung Cell Mol Physiol (2008) 1.59
Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int (2003) 1.58
Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int (2009) 1.56
Ischemia-reperfusion and immediate T cell responses. Cell Immunol (2007) 1.55
The distant organ effects of acute kidney injury. Kidney Int (2011) 1.55
Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol (2005) 1.54
Kidney-derived stromal cells modulate dendritic and T cell responses. J Am Soc Nephrol (2009) 1.51
Organ crosstalk: the role of the kidney. Curr Opin Crit Care (2009) 1.50
Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol (2006) 1.50
The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med (Berl) (2009) 1.49
Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol (2010) 1.44
Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model. Clin Cancer Res (2005) 1.44
Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) (2009) 1.38
Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol (2003) 1.33
Uremic lung: new insights into a forgotten condition. Kidney Int (2008) 1.31
Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2003) 1.27
Kidney transplantation in the elderly. Semin Nephrol (2009) 1.27
Transfer of lymphocytes from mice with renal ischemia can induce albuminuria in naive mice: a possible mechanism linking early injury and progressive renal disease? Am J Physiol Renal Physiol (2006) 1.25
Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis (2013) 1.24
Crystal structures of bacterial lipoprotein localization factors, LolA and LolB. EMBO J (2003) 1.21
Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int (2003) 1.21
Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest (2005) 1.19
Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes. Kidney Int (2008) 1.17
Kidney ischemia-reperfusion injury induces caspase-dependent pulmonary apoptosis. Am J Physiol Renal Physiol (2009) 1.16
Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury. Am J Transplant (2005) 1.16
Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Transplantation (2014) 1.16
Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation (2002) 1.12
Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol (2008) 1.11
Distant-organ changes after acute kidney injury. Nephron Physiol (2008) 1.11
African American and non-African American patients' and families' decision making about renal replacement therapies. Qual Health Res (2012) 1.09
Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol (2002) 1.09
15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J Am Soc Nephrol (2002) 1.08
Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2'-deoxyguanosine in human urine. Cancer Epidemiol Biomarkers Prev (2002) 1.05
Kidney-lung crosstalk in the critically ill patient. Blood Purif (2009) 1.04
Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.03
Blocking Fas ligand on leukocytes attenuates kidney ischemia-reperfusion injury. J Am Soc Nephrol (2011) 1.03
B cells limit repair after ischemic acute kidney injury. J Am Soc Nephrol (2010) 1.01
Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol (2003) 0.99
Stathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury. Am J Physiol Renal Physiol (2006) 0.99
Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsies. Arch Pathol Lab Med (2008) 0.99
The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens (2003) 0.96
Interleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injury. Exp Lung Res (2011) 0.96
Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol (2006) 0.96
DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation (2009) 0.96
Selecting renal replacement therapies: what do African American and non-African American patients and their families think others should know? A mixed methods study. BMC Nephrol (2013) 0.95
Immune modulation of acute kidney injury. J Am Soc Nephrol (2006) 0.94
Overexpression of SSAT in kidney cells recapitulates various phenotypic aspects of kidney ischemia-reperfusion injury. J Am Soc Nephrol (2004) 0.94
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation (2013) 0.92
Paracrine and differentiation mechanisms underlying stem cell therapy for the damaged kidney. Am J Physiol Renal Physiol (2005) 0.92
Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases. Am J Physiol Renal Physiol (2006) 0.92
Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury. Am J Physiol Renal Physiol (2009) 0.91
Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions. BMC Med Inform Decis Mak (2012) 0.90
The providing resources to enhance African American patients' readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial. BMC Nephrol (2012) 0.90
The role for T cell repertoire/antigen-specific interactions in experimental kidney ischemia reperfusion injury. J Immunol (2009) 0.90
Opening and closing of the hydrophobic cavity of LolA coupled to lipoprotein binding and release. J Biol Chem (2008) 0.88
Silent acute rejection during prolonged delayed graft function reduces kidney allograft survival. Transplantation (2002) 0.87
Identification of stathmin as a novel marker of cell proliferation in the recovery phase of acute ischemic renal failure. Am J Physiol Cell Physiol (2003) 0.87
Acute renal venous obstruction is more detrimental to the kidney than arterial occlusion: implication for murine models of acute kidney injury. Am J Physiol Renal Physiol (2011) 0.87
Effects of anti-adhesive therapy on kidney biomarkers of ischemia reperfusion injury in human deceased donor kidney allografts. Clin Transplant (2010) 0.87
Effect of T cells on vascular permeability in early ischemic acute kidney injury in mice. Microvasc Res (2009) 0.86
Surrogate markers for long-term renal allograft survival. Am J Transplant (2004) 0.85
Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. Transpl Immunol (2010) 0.85
Pulmonary endothelial cell activation during experimental acute kidney injury. Shock (2011) 0.85
Effects of acid aspiration-induced acute lung injury on kidney function. Am J Physiol Renal Physiol (2008) 0.85
Urinary biomarkers in acute kidney transplant dysfunction. Nephron Clin Pract (2010) 0.85
Utility and limitations of serum creatinine as a measure of renal function in experimental renal ischemia-reperfusion injury. Transplantation (2002) 0.83
Immune responses in kidney preservation and reperfusion injury. J Investig Med (2004) 0.83
Large-scale preparation of the homogeneous LolA lipoprotein complex and efficient in vitro transfer of lipoproteins to the outer membrane in a LolB-dependent manner. Protein Sci (2007) 0.83
Renal transplantation at the Johns Hopkins Comprehensive Transplant Center. Clin Transpl (2003) 0.82
Meta-analysis of molecular response of kidney to ischemia reperfusion injury for the identification of new candidate genes. BMC Nephrol (2013) 0.82
Renal expression and activity of the germinal center kinase SK2. Am J Physiol Renal Physiol (2003) 0.82
Pathophysiological contributions of fucosyltransferases in renal ischemia reperfusion injury. J Immunol (2002) 0.82
Intestinal microbiota-kidney cross talk in acute kidney injury and chronic kidney disease. Nephron Clin Pract (2014) 0.82
Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5. Am J Physiol Renal Physiol (2011) 0.82
Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection. Transplantation (2010) 0.82
Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 0.82
Limiting deleterious cross-talk between failing organs. Crit Care Med (2004) 0.81
The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice. Transpl Immunol (2009) 0.81
Crystallization and preliminary crystallographic study of the outer-membrane lipoprotein receptor LolB, a member of the lipoprotein localization factors. Acta Crystallogr D Biol Crystallogr (2003) 0.81
Delayed kidney allograft function - what does it tell us about acute kidney injury? Contrib Nephrol (2011) 0.81
Ischemic acute tubular necrosis models and drug discovery: a focus on cellular inflammation. Drug Discov Today (2006) 0.81
Isometric tubular epithelial vacuolization in renal allograft biopsy specimens of patients receiving low-dose intravenous immunoglobulin for a positive crossmatch. Transplantation (2004) 0.81